Tag: rare disease

October 14, 2018

10 Drugs Going Off Patent in 2018

A look at 10 drugs going off patent in 2018, plus an overview of what loss of exclusivity means for...
May 10, 2018

Novelion Therapeutics Reports First Quarter 2018 Financial Results

Novelion Therapeutics (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing and commercializing therapies for individuals living with rare diseases, today reported...
April 26, 2018

Shire: 1st Quarter Results

Shire (LSE: SHP, NASDAQ: SHPG), the leading global biotech company focused on rare diseases, announces unaudited results for the three...
April 19, 2018

Genetics Update: Q1 in Review

With Q1 2018 officially in the books, here the Investing News Network takes a look back at what some of...
April 17, 2018

Shire Receives FDA Approval for Rare Disease Drug, Share Price Rises

Shire has received another FDA approval with the second approval for Vonvendi, a treatment for perioperative bleeding management in adults...
April 17, 2018

Shire: FDA APPROVES VONVENDI

Shire (LSE: SHP, NASDAQ: SHPG), the global  biotechnology leader in rare disease, today announced the U.S. Food and Drug Administration...
April 16, 2018

Shire plc : Shire Announces Sale of Oncology Business to Servier for $2.4 Billion

Shire (LSE: SHP, NASDAQ: SHPG) the leading global biotechnology company focused on rare diseases announces today that it has entered...